Your browser doesn't support javascript.
loading
Radotinib attenuates TGFß -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing.
Baek, Suji; Kwon, Seung Hae; Jeon, Joo Yeong; Lee, Gong Yeal; Ju, Hyun Soo; Yun, Hyo Jung; Cho, Dae Jin; Lee, Kang Pa; Nam, Myung Hee.
Afiliação
  • Baek S; Research and Development Center, UMUST R&D Corporation, 84, Madeul-ro 13-gil, Dobong-gu, 01411, Seoul, Republic of Korea.
  • Kwon SH; Seoul Center, Korean Basic Science Institute, 02841, Seoul, Republic of Korea.
  • Jeon JY; Seoul Center, Korean Basic Science Institute, 02841, Seoul, Republic of Korea.
  • Lee GY; Il Yang Pharm Co.,Ltd, 37, Hagal-ro 136 Beon-gil, Giheung-gu, 17096, Yongin-si, Gyeonggi-do, Republic of Korea.
  • Ju HS; Il Yang Pharm Co.,Ltd, 37, Hagal-ro 136 Beon-gil, Giheung-gu, 17096, Yongin-si, Gyeonggi-do, Republic of Korea.
  • Yun HJ; Il Yang Pharm Co.,Ltd, 37, Hagal-ro 136 Beon-gil, Giheung-gu, 17096, Yongin-si, Gyeonggi-do, Republic of Korea.
  • Cho DJ; Il Yang Pharm Co.,Ltd, 37, Hagal-ro 136 Beon-gil, Giheung-gu, 17096, Yongin-si, Gyeonggi-do, Republic of Korea.
  • Lee KP; Research and Development Center, UMUST R&D Corporation, 84, Madeul-ro 13-gil, Dobong-gu, 01411, Seoul, Republic of Korea. umustrnd@naver.com.
  • Nam MH; Seoul Center, Korean Basic Science Institute, 02841, Seoul, Republic of Korea. nammh@kbsi.re.kr.
BMC Pharmacol Toxicol ; 23(1): 93, 2022 12 15.
Article em En | MEDLINE | ID: mdl-36522756

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Fibrose Pulmonar Idiopática Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: BMC Pharmacol Toxicol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Fibrose Pulmonar Idiopática Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: BMC Pharmacol Toxicol Ano de publicação: 2022 Tipo de documento: Article